MKI67 and breast cancer: In our study, we also found that patients whose Ki67 expression decreased after NAC had longer OS and DFS than the patients without a decrease in Ki67, which is consistent with a previous study of Cabrera-Galeana et al,[41] suggesting that Ki67 reduction after NAC would be a marker to predict a better prognosis for BC patients.